Estimated longevity benefit: +1.0 years. Evidence score: 96/100.
Urolithin A is a postbiotic metabolite that activates mitophagy, the process of recycling damaged mitochondria within cells. By improving mitochondrial quality control, it enhances cellular energy production and muscle function, which are critical for maintaining metabolic health and physical independence as we age.
Urolithin A is a postbiotic metabolite produced when gut bacteria process ellagitannins from pomegranates, walnuts, and berries. Only about 40% of people can produce meaningful amounts naturally, so supplemental urolithin A (Mitopure by Timeline/Amazentis) bypasses this limitation. A 2022 RCT in Cell Reports Medicine (Singh A et al., PMID 35584623) showed ~12% improvement in muscle strength and aerobic endurance in middle-aged adults over 4 months. A 2022 JAMA Network Open RCT (Liu S et al., PMID 35050355) in older adults confirmed improved muscle endurance and mitochondrial gene expression. A 2025 Nature Aging RCT (Denk D et al., PMID 41174221) found 4 weeks of urolithin A expanded naive-like CD8+ T cells and reduced immune exhaustion markers — extending the mechanism beyond muscle to immune rejuvenation. A 2024 systematic review (Kuerec AH et al., Ageing Research Reviews, PMID 39002645) of 5 human studies confirmed dose-dependent anti-inflammatory effects, autophagy upregulation, and improved muscle outcomes. The 2019 Nature Metabolism first-in-human study established safety and demonstrated mitophagy biomarker upregulation in elderly subjects. Direct lifespan extension data in humans does not yet exist, but urolithin A now has one of the broadest human clinical evidence bases of any mitophagy-targeting compound. By clearing dysfunctional mitochondria, urolithin A reduces systemic inflammation and oxidative stress, addressing a core hallmark of aging known as mitochondrial dysfunction. The evidence is robust for physiological improvements, though long-term longevity data is still being gathered.
Target Goal: Mitophagy serves as the essential quality control mechanism for your cells, ensuring that only healthy, high-performing mitochondria remain to power your tissues. Targeting this pathway directly addresses the decline in muscle strength and aerobic capacity that typically begins in middle age. - Activate mitophagy — the selective recycling of damaged mitochondria that accumulate with age - Improve cellular energy production and mitochondrial respiratory capacity - Support muscle function, endurance, and exercise recovery - Bypass the gut microbiome limitation (only ~40% of people naturally produce adequate urolithin A from food)
Understanding Mitophagy: Mitochondria are the power plants of your cells, but they become inefficient and "leaky" as they age, producing harmful waste products instead of energy. Understanding the difference between general antioxidants and organelle-specific recycling is key to appreciating why urolithin A is a unique tool in the longevity toolkit. - Your cells contain thousands of mitochondria that produce energy (ATP) - With age, damaged mitochondria accumulate, producing excess reactive oxygen species and less energy - Mitophagy is the quality control process that removes dysfunctional mitochondria and stimulates production of new ones - Urolithin A is one of the few compounds shown to reliably activate this pathway in human clinical trials - This is different from general antioxidants — it targets the root cause (damaged organelles) rather than just neutralizing free radicals
Beginner Protocol (Month 1): Starting with a consistent daily dose allows your body to establish the necessary cellular environment for mitochondrial turnover to begin. Monitoring your baseline energy and recovery patterns is essential for identifying the subtle shifts that occur during the initial weeks of supplementation. - Start with 500mg urolithin A daily for the first month - Take in the morning, with or without food (urolithin A is well-absorbed either way) - No loading phase required — effects build gradually - Monitor for any GI sensitivity (uncommon but possible) - Note your baseline energy levels, exercise recovery time, and any fatigue patterns
Standard Protocol (Month 2+): Maintaining a steady tissue concentration of urolithin A over several months is required to achieve the muscle endurance and strength gains observed in clinical trials. While higher doses are well-tolerated, the primary goal at this stage is long-term compliance to support continuous mitochondrial renewal. - 500mg daily is the clinically studied dose with proven benefits - 1000mg daily was also tested in trials and showed dose-dependent improvements in some markers - Consider stepping up to 1000mg if well-tolerated and budget allows - Consistency is more important than dose — daily dosing for months is how clinical benefits were achieved - Best taken at the same time each day to maintain steady tissue levels
Food Sources vs Supplements: While pomegranates and berries provide numerous health benefits, relying on them for urolithin A production is unreliable due to the specific gut bacteria required for conversion. Supplementation provides a predictable dose of the active metabolite, bypassing the genetic and microbial variability that prevents most people from producing it naturally. - Ellagitannin-rich foods (precursors): pomegranates (highest), walnuts, raspberries, strawberries, blackberries - Your gut bacteria must convert ellagitannins → ellagic acid → urolithin A - Only ~40% of people have the right gut microbiome composition to produce meaningful amounts - Even among producers, amounts vary widely based on microbiome health - A supplement (like Mitopure/Timeline) bypasses this bottleneck entirely — you get the active compound directly - Still eat pomegranates and berries for their other polyphenols, fiber, and nutrients
Combining With Other Interventions: Mitochondrial health is a multi-step process that benefits from synergistic inputs like regular exercise and complementary nutrients. Combining urolithin A with physical activity maximizes the signal for mitochondrial biogenesis, ensuring that old power plants are replaced by new, efficient ones. - Pairs well with exercise — urolithin A may enhance exercise-induced mitophagy and reduce muscle damage - Complementary to CoQ10 (supports electron transport chain) and creatine (cellular energy support) - Consider alongside NAD+ precursors (NMN/NR) for comprehensive mitochondrial support - No known negative interactions with common supplements
Quality and Sourcing: Because the manufacturing process for pure urolithin A is complex, choosing a verified source is critical for ensuring you are receiving the active compound rather than generic pomegranate extract. Look for third-party verification to confirm the purity and concentration of the active metabolite in your supplement. - Look for clinically studied forms — Mitopure (by Timeline/Amazentis) is the most researched - Third-party testing (NSF, USP, or ConsumerLab) for purity verification - Standardized urolithin A content clearly listed on label - Avoid proprietary blends that don't disclose exact urolithin A amounts - Store at room temperature, away from direct sunlight
Monitoring Progress: Because mitochondrial turnover is a slow biological process, tracking functional markers over several months is more effective than looking for immediate changes. Improvements in endurance and walking speed are the most reliable indicators that the intervention is having a meaningful impact on your physical capacity. - Subjective: Track energy levels, exercise endurance, recovery time, and fatigue patterns - Exercise capacity: Note improvements in endurance, walking speed, or muscle performance - Blood work (advanced): Acylcarnitines and certain mitochondrial biomarkers may shift, but these are research-grade tests - The JAMA Network Open trial showed 12% improvement in muscle endurance at 4 months — this is what to expect directionally - Keep a simple log: weekly energy score (1-10), exercise performance notes
Expected Timeline: Understanding the delayed response curve of mitophagy helps maintain compliance during the first few months when changes are occurring only at the cellular level. The most significant functional benefits typically emerge after the 12-week mark, coinciding with the timeline of major human clinical trials. - Weeks 1-4: Mitophagy biomarkers begin to shift at the cellular level; most people won't notice subjective changes yet - Months 2-3: Subtle improvements in exercise endurance and recovery may become noticeable - Month 4: Clinical trials showed measurable muscle endurance gains (12% improvement in 6-minute walk test) - Month 4+: Continued benefits with ongoing use; mitochondrial quality improvement is an ongoing process - This is not an acute energy supplement — don't expect a caffeine-like boost; benefits are gradual and cumulative
Common Mistakes: The most frequent error is treating urolithin A like a stimulant and discontinuing use when an immediate energy boost is not felt. Patience is required to allow the body to recycle years of accumulated mitochondrial damage and build a new, more efficient cellular infrastructure. - Expecting immediate energy boost — mitophagy takes weeks to months to produce noticeable effects - Stopping too early — at least 2-4 months of consistent use is needed to see clinical-level benefits - Relying solely on pomegranate juice as a source — the sugar content is high and urolithin A conversion is unreliable - Choosing cheap, untested brands with unknown actual urolithin A content - Mega-dosing beyond 1000mg — no clinical data supports higher doses, and more is not necessarily better
Safety and Cautions: Urolithin A has an excellent safety profile in multiple human trials, but it is important to be aware of the populations where research is still lacking. Following established safety guidelines ensures that you can pursue mitochondrial rejuvenation without unnecessary risk. - Generally well-tolerated in clinical trials with safety profiles similar to placebo - Mild GI effects (bloating, mild nausea) possible initially — usually resolve within a week - Long-term safety data extends to about 4-6 months from published trials; longer-term data is still accumulating - Not studied in pregnancy, breastfeeding, or children — avoid in these populations - No significant drug interactions identified in current research, but inform your doctor if taking medications - If you have a mitochondrial disorder, consult a specialist before use
Supports
Singh A et al.
RCT in middle-aged adults: 500mg and 1,000mg urolithin A improved hamstring muscle strength by ~12% and improved aerobic endurance vs. placebo after 4 months.
View paperSupports
Andreux PA et al.
First-in-human study showing urolithin A upregulated mitophagy biomarkers and improved mitochondrial respiratory capacity in elderly subjects.
View paperSupports
Liu S et al.
Demonstrated urolithin A's anti-inflammatory mechanism through NF-κB pathway inhibition and gut barrier function improvement.
View paperSupports
Kuerec AH, Lim XK, Khoo ALY, Sandalova E, Guan L, Feng L, Maier AB
Systematic review of 5 human studies (n=250, ages 36-88): urolithin A at 10-1,000mg/day showed dose-dependent anti-inflammatory effects, upregulated mitochondrial genes, markers of autophagy, and improved muscle strength and endurance.
View paperSupports
Liu S et al.
RCT in older adults (65-90 yrs) showing 1,000mg urolithin A improved muscle endurance and mitochondrial gene expression markers after 4 months.
View paperSupports
Andreux PA et al.
First-in-human study demonstrating urolithin A is safe and upregulates mitophagy biomarkers and mitochondrial health markers in elderly subjects.
View paperSupports
Denk D, Singh A, Kasler HG, D'Amico D, Rey J et al.
RCT (n=50, ages 45-70): 1,000mg/day urolithin A for 4 weeks expanded peripheral naive-like CD8+ T cells, reduced exhaustion markers, and increased CD8+ fatty acid oxidation capacity — evidence of mitophagy-driven immune rejuvenation.
View paper